Key facts
- This page summarizes Steven Girgenti's Form 4 filing for bioAffinity Technologies, Inc. (BIAF).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2024, 16:00.
Steven Girgenti - 03 Apr 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)
- Reporting relationship
- Director
- Issuer ticker
- BIAF
- Reported as of
- 03 Apr 2024
- Net transaction value
- +$323
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2024, 16:00:20 UTC
- Prior SEC filing
- 29 Mar 2024
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven Girgenti filed Form 4 for bioAffinity Technologies, Inc. (BIAF) on 24 Apr 2024.
Change
- Previous filing in this sequence was filed on 29 Mar 2024.
- Current net transaction value: +$323.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIAF
transaction
Common Stock
Options Exercise
- Transaction value
- $75,224
- Shares
- +64,848
- Change %
- +6.5%
- Price
- $1.16
- Shares after
- 1,056,606
- Date
- 03 Apr 2024
- Ownership
- Direct
BIAF
transaction
Common Stock
Tax liability
- Transaction value
- $74,901
- Shares
- -33,438
- Change %
- -3.2%
- Price
- $2.24
- Shares after
- 1,023,168
- Date
- 03 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
BIAF
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,955
- Date
- 03 Apr 2024
- Ownership
- By Trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIAF
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -64,848
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 03 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,848
- Exercise price
- $1.16
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld to cover the exercise price of the options exercised.
Footnote F2
These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F3
This option vested in 7 equal monthly installments beginning on April 28, 2014.